Clin Infect Dis

Patient-centered HIV Care Model Team

Background. Human immunodeficiency virus (HIV) viral suppression (VS) decreases morbidity, mortality, and transmission risk. Methods. The Patient-centered HIV Care Model integrated community-based pharmacists with HIV medical providers and required them to share patient clinical information, identify therapy-related problems, and develop therapy-related action plans. Results. The 765 enrolled participants were 43% non-Hispanic black, 73% male, with a median age of 48 years; 421 and 649 were included in the adherence and VS analyses, respectively. Overall, proportions adherent to therapy remained unchanged. However, VS improved a relative 15% (75% to 86%, P < .001). Higher PDC (adjusted odds ratio [AOR], 1.74 per 1-level increase in PDC category [95% confidence interval {CI}, 1.30–2.34]) and baseline VS (AOR, 7.69 [95% CI, 3.96–15.7]) were associated with postimplementation VS. Although non-Hispanic black persons (AOR, 0.29 [95% CI, .12–.62]) had lower odds of suppression, VS improved a relative 23% (63% to 78%, P < .001). Conclusions. Integrated care models between community-based pharmacists and primary medical providers may identify and address HIV therapy–related problems and improve VS among persons with HIV.

30953062

PMC6821576

Journal Article

CC999999/ImCDC/Intramural CDC HHS/United States

CDC Public Access